Item record/more information http://hdl.handle.net/10197/3144 Publisher's statement þÿ T h i s i s t h e a u t h o r s v e r s i o n o f a w o r k t h a t Running Title: Role of Rab11 and Rab4 in recycling of the human prostacyclin receptor.
INTRODUCTION
The prostanoid prostacyclin (prostaglandin (PG)I 2 ) plays a central role in haemostasis acting as a potent inhibitor of platelet aggregation and as an endothelium-derived vasodilator [1] . It exerts proinflammatory and anti-proliferative properties in vitro [2, 3] and offers cytoprotection during acute myocardial ischemia or hypoxia [4] . The actions of prostacyclin generally counteract those of thromboxane (TX) A 2 , and, thus, factors dictating their relative levels and/or the cellular responses are central to haemostasis and vessel tone [5] . Imbalances in prostacyclin or TXA 2 are widely associated with a range of vascular diseases, including thrombosis, stroke, systemic and pulmonary hypertensions, myocardial infarction and atherosclerosis [6] [7] [8] [9] [10] . Moreover, mice deficient in prostacyclin receptors (IPs) show impaired responses to thrombotic stimuli [2] and develop more severe pulmonary hypertension and vessel remodelling following chronic hypoxia [11] .
The prostacyclin receptor (IP), a member of the G-protein coupled receptor (GPCR) superfamily, is primarily coupled to Gs/adenylyl cyclase activation but may regulate other secondary effectors including Gq/phospholipase (PL)C activation, Gi/ adenylyl cyclase activation, amongst others [12] [13] [14] [15] .
The IP is subject to a number of post-translational modifications that are critical in regulating its function.
For example, the human IP (hIP) undergoes both isoprenylation and palmitoylation within its carboxylterminal (C)-tail domain and collectively these lipidations modulate its G-protein/effector signaling and internalization post-agonist activation [16] [17] [18] . Both the human (h) and mouse (m) IPs are isoprenylated through attachment of a C-15 farnesyl isoprenoid to a Cys within its highly conserved -'CAAX' motif [16, 17] . The hIP is dually palmitoylated at Cys 308 and Cys 311 and together with the farnesyl-Cys 383methyl ester, at Cys 383 , confers a double loop structure within its C-tail domain to orientate and provide the critical structural domains for interaction with coupling G proteins and, possibly, with components of the protein trafficking machinery to modulate both G protein/effector signaling and receptor internalization post-agonist activation [16] [17] [18] .
A critical feature of GPCR signaling is desensitization, the process(es) that regulates its ability to respond to repeated challenge to its own ligand or indeed regulates cross-talk between other related or unrelated signaling systems [19, 20] . Desensitization is usually initiated by phosphorylation, such as by the second messenger-protein kinases and/or by the G protein-coupled receptor kinases (GRKs) [19, 20] .
GRK phosphorylation of the agonist-occupied GPCR may in turn recruit the non-visual β-arrestin1/2 which binds with high affinity sterically hindering G-protein coupling, desensitizing GPCR signalling [20] [21] [22] . Moreover, depending on the receptor, β-arrestin(s) may serve as adapters targetting the GPCR to components of the endocyctic machinery, such as to clathrin coated pits through association with clathrin and the β2-adaptin subunit of the heterotetrameric AP2 adaptor complex [20, 21] to induce sequestration and internalization of the desensitized GPCR from the plasma membrane. Following internalization, the GPCR may undergo further intracellular trafficking, such as through Rab-dependent vesicular transport, ultimately leading to either GPCR dephosphorylation and recyclization (resensitization), GPCR degradation (down-regulation) or indeed GPCR recruitment into scaffolds/subcellular microdomains for participation in other novel/distinct signalling cascades [20] [21] [22] [23] [24] .
The Rab GTPases control multiple steps of the trafficking [25, 26] , either independently of /or in association with the β-arrestin/adapter mechanisms. Rab5a is present at the plasma membrane and in early endosomes and mediates endocytosis and transport or fusion of endocytic vesicles with early endosomes [27] . Rab4a and Rab11a are associated with early and late recycling endosomes and can mediate GPCR recycling through either the so-called "short pathway" and the "long pathway", respectively [28] while Rab7 is also associated with late endosomes and can regulate transport to lysosomes [29] . While much is known about the events leading to GPCR desensitization and internalization, significantly less is understood about the intracellular sorting mechanisms dictating GPCR recyclization and /or transport to the lysosomes for degradation.
A number of independent studies have established that the prostacyclin receptor (IP) undergoes agonist-induced phosphorylation, desensitization and down-regulation in human platelets and other cell types, providing an important mechanism of fine-tuning the cellular responses to prostacyclin in vivo [30] [31] [32] [33] [34] . While the hIP undergoes agonist-induced protein kinase (PK)C phosphorylation within its C-tail domain, desensitizing its signaling [33] , its internalization is entirely independent of both PKC and the classic GRK/β-arrestin-mediated mechanism [34] . Through recent investigations, we have established that the hIP undergoes rapid agonist-induced internalization through a mechanism involving its direct interaction with Rab5a [35] . In general, it is thought that the carboxyl-terminal (C)-tail domain of a given GPCR can act as an important determinant of desensitization and internalization, frequently being enriched in Ser/Thr residues for phosphorylation and/or containing structural motifs for interaction with components of various trafficking pathways, such as β-arrestin or Rab protein binding domains [20, 21, 36, 37] . In the case of the hIP, while deletion of its C-tail domain of the hIP did not fully impair agonistinduced internalization or, indeed, association with Rab5 per se, trafficking of the truncated hIP (hIP ∆312 and hIP ∆307 ) was substantially altered suggesting the C-tail domain contains structural determinant(s) for hIP sorting post Rab5-mediated endocytosis [35] . Hence, the aim of the current study was to apply the yeast-two-hybrid (Y2H) screening approach to identify interactants of the C-tail domain of the hIP, in particular with the view to possibly identifying those proteins that influence hIP trafficking in response to agonist stimulation. Herein, we have discovered a novel interaction with Rab11a that is enhanced by agonist-activation of the hIP. The functional implications of this interaction with Rab11a, and the possible role of Rab4a, in regulating agonist-induced trafficking of the hIP are investigated.
EXPERIMENTAL PROCEDURES

Materials.
Cicaprost was obtained from Schering AG (Berlin, Germany). Rat monoclonal anti-HA-3F10 horse radish peroxidase (HRP)-conjugated antibody (25µg/ml) was obtained from Roche. Mouse monoclonal anti-hemagglutinin (HA)-101R antibody (1 mg/ml) was obtained from Eurogentec; anti-FLAG © M2 monoclonal antibody (F3165) was sourced from Sigma; anti-Myc (M911) M2 mouse monoclonal antibody was from Cell Signalling Technology; anti-GFP (FL), anti-Rab4 (D-20), anti-Rab11 (H-87), HRP-conjugated goat anti-mouse (400 µg/ml) and HRP-conjugated goat anti-rabbit (400 µg/ml) antibodies were from Santa Cruz; mouse anti-Tfr (A-11130) was from molecular probes; Anti HDJ-2 antibody was from Neomarkers. AlexaFluor594 goat anti-mouse (2 mg/ml) and AlexaFluor488 goat anti-rabbit (2 mg/ml) antibodies were from Molecular Probes.
Yeast-2-Hybrid Screening and Yeast Matings.
A human kidney cDNA library cloned in-frame with the activation domain of the yeast GAL4 transcriptional activator in the yeast prey plasmid pACT2 and pre-transformed into Saccharomyces cerevisiae (S.c) Y187 was obtained from Clontech (3.5 X 10 6 independent clones; HY4043AH). cDNA fragments encoding the carboxyl-terminal (C)-tail domain of the human prostacyclin receptor (hIP), corresponding to amino acids 299 -386 of either the wild type hIP, namely hIP 299-386WT , or of its isoprenylation deficient variant, namely hIP 299-386SSLC ( Figure 1A ), were subcloned in-frame with the DNA-binding domain of GAL4 into the vector pGBKT7 . The resulting bait pGBKT7:hIP 299-386WT and pGBKT7:hIP 299-386SSLC plasmids were transformed into S.c AH109 strain, according to standard protocols (Matchmaker™ Two-Hybrid System 3, Clontech, Protocol No. PT3024-1) and grown on SD Leuplates.
Thereafter, the MATa bait strain S.c. AH109 (pGBKT7:hIP 299-386,SSLC ) was mated with the MATα S.c.Y187 (pACT2; human kidney cDNA library), at a density of 2 x 10 6 cells per ml and a ratio of 30: 1 bait : prey cells, where 1 X 10 8 individual transformants/diploids were screened. After 24 hr growth in SD/Trp − ,Leu − (DDO, double dropout) at 30 °C, resulting diploids were plated on SD/Trp − , Leu − , His − , Ade − medium (quadruple drop out (QDO) medium; Clontech, Protocol No. PT3024-1) and plates were maintained for 15 days at 30 °C. Recombinant pACT2 plasmid DNA was extracted from each putative interactant [38] and transformed into supercompetent Escherichia (E) coli cells.
Following retransformation of the pACT2-based plasmid from putative interactants into S.c Y187 and remating with a range of bait strains including S.c AH109 (pGBKT7: hIP 299-386WT ), S.c AH109 (pGBKT7: hIP 299-386SSLC ) and AH109 (pGBKT7), positive interactants were selected on the basis of their ability to express the HIS3, ADE2 and lacZ genes by growth on the high stringency QDO medium and by their ability to cleave X-β-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside), as measured by the filter lift assay from SD/Trp − For analysis of protein expressions in the transformed S.c. AH109 (pGBKT&) bait or S.c Y187 (pACT2) prey strains, protein was extracted according to recommended protocols (Clontech, Protocol No.
PT3024-1), resolved by SDS-PAGE, on 12.5% acrylamide gels, and screened by western blot analysis using anti-Myc (9B11) or anti-FLAG M2 monoclonal antibodies, respectively, followed by chemiliminescence detection [16] .
Subcloning and Site-Directed Mutagenesis.
The plasmid pcDNA3:Rab11a was obtained from the Missouri S&T cDNA Resource Center. Conversion of Ser 25 to N 25 to generate pcDNA3:Rab11a S25N was performed using pcDNA3:Rab11a as template and the sense/antisense primer pair (5'TCT GGT GTT GGA AAG AAT AAT CTC CTG TCT CGA). The plasmid pcDNA3:Rab11a Q70L was generated using pcDNA3:Rab11a as template and sense/antisense primer pair (5'TGG GAC ACA GCA GGG CTA GAGCGA TAT CGA GCT). The plasmid pCMV5:Rab4 was previously described [39] . Conversion of Ser 22 to N 22 to generate pCMV5:Rab4 S22N was achieved using pCMV5:Rab4a as template and the sense/antisense primer pair (5' GCA GGA ACT GGC AAA AAT TGC TTA CTT CAT CAG). The plasmid pCMV5:Rab4a Q67L was generated using pCMV5:Rab4a as template and sense/antisense primer pair (5' TGG GAT ACA GCA GGA CTA GAA CGA TTC AGG TCC). For each primer pair, sequences shown correspond to the sense primer and the identity of the mutator codon is in boldface italics. All site directed mutagenesis was performed using QuikChange TM (Stratagene) site-directed mutagenesis and mutations were validated by DNA sequence analysis. The full length cDNAs encoding Rab11a, Rab11a S25N , Rab11a Q70L , Rab4a, Rab4a S22N and Rab4a Q67L were subcloned in frame into the Xho1-BamH1 sites of pEGFPC1 to generate pEGFPC1:Rab11a, pEGFPC1:Rab11a S25N , pEGFPC1:Rab11a Q70L pEGFPC1:Rab4a, pEGFPC1:Rab4a S22N and pEGFPC1:Rab4a Q67L , respectively.
Cell Culture and Transfections.
Human embryonic kidney (HEK) 293 cells were obtained from the American Type Culture Collection and grown in minimal essential medium (MEM) containing 10% foetal bovine serum (FBS).
Routinely, approximately 48 hr prior to transfection, cells were plated at a density of 2 x 10 6 cells/10 cm culture dish in 8 ml media. Thereafter, cells were transiently transfected with 10 µg of pADVA [40] and 25 µg of pCMV-, pcDNA3-or or pEGFPCI-based vectors using the calcium phosphate/DNA co-precipitation procedure, as previously described [41] . Transiently transfected cells were harvested 48 hr after transfection, unless otherwise stated.
HEK.hIP WT , HEK.hIP ∆307 and HEK.hIP ∆312 cells stably over-expressing HA-tagged forms of hIP WT , hIP ∆307 and hIP ∆312 respectively, have been previously described [16, 18] . HEK.β-galactosidase (HEK.β-Gal) cells stably over-expressing the HA-tagged β-galactosidase (β-Gal) from Escherichia coli were generated essentially as previously described [16, 18] .
EA.hy 926 cells were obtained from the Tissue Culture Facility at UNC Lineberger Comprehensive Cancer Center, North Carolina and were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10 % FBS [42] .
Co-immunoprecipitations.
HEK.hIP, HEK.hIP ∆307 , HEK.hIP ∆312 and, as controls HEK 293 or HEK.β-galactosidase (β-Gal) cells were transiently co-transfected with pADVA and either pEGFPC1, pEGFPC1:Rab11a, pEGFPC1:Rab11a S25N , pEGFPC1:Rab11a Q70L or pEGFPC1:Rab4a using the calcium phosphate/DNA coprecipitation procedure [41] . Some 48 hr post-transfection, co-immunoprecipitations were carried out as previously described [35] . Immunoprecipitates and whole cell lysates were resolved by SDS-PAGE on 10% gels and subjected to immunoblotting with anti-GFP (1:1000), anti-Rab4 (1 :1000), anti-Rab11 (1 :1000), anti-HA 3F10-HRP (1:500) antibodies followed by chemiluminescence detection [16] .
ELISA-based Recycling Assays.
HEK.hIP cells (10-cm dishes, 60-70% confluent) were transiently co-transfected with 10 µg pADVA along with 25 µg pcDNA3:Rab11a, pcDNA3:Rab11a S25N , pcDNA3:Rab11a Q70L , pCMV5:Rab4a, pCMV5:Rab4a Q67L or pCMV5:Rab4a S22N or, as controls, with the empty vector equivalents using the calcium phosphate/DNA co-precipitation procedure, as previously described [41] . Some 24 hr post-transfection, cells were transferred to poly-L-lysine (0.001%) pre-coated 24-well plates at a density of 1 x 10 5 cells per well and were cultured for an additional 48 hr. Thereafter, to assess recycling of hIP postagonist stimulation, the media was changed to serum-free MEM and cells were treated with cicaprost (1 µM), or as a control, with vehicle (MEM) for 1 hr at 37 °C to allow receptor internalization to commence.
Cicaprost-containing media was removed by washing cells twice in MEM and the cells were further Following this, the cells were washed three times in TBS and nett changes in cell surface expression of HA-tagged receptor expression was determined colorimetrically at 650 nm using the K-Blue substrate (Neogen Corp), as previously described [17] .
Assessment of Agonist-Induced Trafficking by Confocal Microscopy.
HEK.hIP cells (10-cm dishes, 60-70% confluent) were transiently co-transfected with 10 µg pADVA along with 25 µg pEGFPC1:Rab11a, pEGFPC1:Rab11a S25N , pEGFPC1:Rab11a Q70L or pEGFPC1:Rab4a using the calcium phosphate/DNA co-precipitation procedure, as previously described [41] . Seeding of cells onto coverslips, pre-labelling of cell surface hIPs and treatment with Cicaprost was carried out as described previously [35] .
To monitor agonist-induced changes in the intracellular localization of Rab4 or Rab11 in the human endothelial EA.hy 926 cell line, cells were treated with 1 µM cicaprost prior to fixation, permeabilization and immunolabelling with anti-Rab4 and anti-Rab11 antibody and secondary AlexaFluor488 goat anti-rabbit antibodies. All slides were imaged, at x 63 magnification, using Carl Zeiss Laser Scanning System LSM 510 and Zeiss LSM Imaging Software for acquiring multichannel images with filters appropriate for enhanced GFP, AlexaFluor488 or AlexaFluor594 fluorescence.
Data analyses.
Statistical analyses were carried out using the unpaired Student's t test throughout or, where relevant and specifically indicated in text, using two-way ANOVA employing the GraphPad Prism version 4.00 package. P-values of less than or equal to 0.05 were considered to indicate a statistically significant difference.
RESULTS
Identification of Rab11a as an Interactant of the hIP in Yeast and Mammalian Cells.
It has been recently established that the carboxyl-terminal (C) -tail domain of the human prostacyclin receptor (hIP) may contain critical structural determinants regulating its intracellular vesicular trafficking post -agonist stimulation [35] . Hence, herein, a yeast-two-hybrid (Y2H) screen of a human kidney cDNA library was carried out to identify proteins that specifically interact with the C-tail domain of the hIP ( Figure 1A ). As stated, the hIP is isoprenylated at Cys 383 within its conserved "-CAAX motif"( Figure 1A ;
-C 383 SLC 386 ), a modification that is likely to affect the efficient transport of 'bait:fusion proteins' based on the GAL4 DNA binding domain into the nucleus during the Y2H screen itself [43] . Therefore, at the outset, the human kidney cDNA library was screened with an isoprenylation deficient variant of the C-tail domain, namely hIP 299-386SSLC ( Figure 1A ). To begin with, it was confirmed that the GAL4-fusion proteins based on the hIP 299-386SSLC and, indeed, the hIP 299-386WT were efficiently expressed in the Saccharomyces cerevisiae (S.c) AH109 host ( Figure 1B ). Moreover, whilst the hIP 299-386WT is expressed as both the isoprenylated and non-isoprenylated forms, the hIP 299-386SSLC was expressed exclusively as the nonisoprenylated precursor, consistent with disruption of the "-CAAX motif" ( Figure 1B ).
Following primary high stringency-and secondary-screening of the human kidney cDNA library (complexity, 3.5 X 10 6 individual clones; 1 X 10 8 individual diploids screened), a number of independent clones were identified that encoded Rab11a. This interaction was further tested by direct mating of the MATα S.c Y187 (pACT:Rab11a) strain with the MATa S.c AH109 bait strain transformed with recombinant pGBKT7 encoding either the original hIP 299-386SSLC or the hIP 299-386WT and, as controls, with the unrelated bait p53 or the empty pGBKT7. While each of the bait strains mated successfully with the prey strain to generate diploids, strains harbouring either the empty vector pGBKT7 alone or encoding p53 failed to show any interaction with Rab11a ( Figure 1C ). Conversely, strains encoding both the original bait hIP 299-386SSLC and indeed its wild type equivalent hIP 299-386WT showed a strong interaction Rab11a ( Figure 1C ). Based on these data, it appears that the C-tail domain of the hIP can specifically interact with Rab11a and that interaction does not appear to be dependent on the isoprenylation status of the hIP.
Thereafter, the ability of Rab11a to interact with the hIP expressed in mammalian cells was investigated. To this end, a previously characterized HEK.hIP cell line, that stably over-expresses a hemagglutinin (HA)-tagged form of the hIP [18] , was co-transfected with plasmids encoding green fluorescent protein (GFP)-tagged forms of Rab11a, Rab11a S22N 
Effect of Rab11a on Recycling of the hIP Post-Cicaprost Stimulation.
To further examine the interaction of the hIP with Rab11a in mammalian cells, its co-localization with GFP-tagged Rab11a, Rab11a S22N and Rab11a Q70L in HEK.hIP cells was investigated by confocal microscopy. Initially, only HA-hIPs located at the cell surface were pre-labelled with anti-HA 101R at 4 o C; thereafter, HA-hIP expression was either analysed directly (0 hr) or following incubation of cells with 1 µM cicaprost at 37 °C for 2 hr or 4 hr. In the absence of agonist stimulation, the preimmunolabelled HA-hIPs were detected exclusively at the cell surface as expected, whereas GFP-Rab11a exhibited a small amount of preformed vesicular staining, but was mainly present in a diffuse cytosolic pattern with no co-localization between the hIP and Rab11a evident ( Figure 3A , Rab11a WT , 0 hr). Thereafter, the effect of over-expression of Rab11a on recycling of the hIP was examined by monitoring nett changes in its cell surface expression by an ELISA-based assay in response to agonist stimulation. To this end, HEK.hIP cells were pre-incubated with cicaprost (1 µM, 1 hr at 37 o C) to initiate the internalization process; thereafter, following agonist removal, cells were incubated at 37 o C for 0 -4 hr and the overall nett level of recycling of the HA-hIP to the plasma membrane assessed by ELISA.
To begin with, it was determined that at 1 hr post-cicaprost stimulation, the level of cell surface hIP expression was 63.2 ± 2.79 % of that pre-agonist stimulation (ie approximately 40% of the hIP internalized) and that over-expression of Rab11a, Rab11a S22N or Rab11a Q70L did not significantly affect the level of internalization per se (p < 0.1). The presence of significant levels of endogenous Rab11 and over-expressed Rab11a, Rab11a S22N or Rab11a Q70L in HEK.hIP cells was confirmed by western blot analysis ( Figure 4A ). Over-expression of Rab11a significantly increased recycling of the hIP to the plasma membrane relative to that of mock (pcDNA)-transfected cells ( Figure 4B ; p = 0.0027, ANOVA), with most significance observed between 1.5 -2 hours post-agonist stimulation (p = 0.038 and p = 0.009, respectively). At 3 hr and 4 hr post-cicaprost stimulation, the level of recycling stabilized at approximately 80% cell surface expression, with no significant difference between mock-transfected or Rab11a-transfected cells evident ( Figure 4B ). Hence, it appears that some 50% of the internalized hIP does not recycle to the plasma membrane and that this is not influenced by the level of Rab11a.
Consistent with this, over-expression of the GTPase-deficient Rab11a Q70L did not alter the overall profile or extent of recycling of the hIP relative to the wild type Rab11 at any of the time points examined ( Figure 4C ; p = 0.6005, ANOVA). On the other hand, over-expression of Rab11a S22N significantly impaired recycling of the hIP relative to that of the wild type Rab11a ( Figure 4D ; p = 0.0001, ANOVA) and relative to mock-transfected cells (p = 0.0001; ANOVA).
Cicaprost-induced movement of Endogenous Rab11 in EA.hy 926 cells.
In order to further investigate the involvement of Rab11 in trafficking of the hIP, the ability of cicaprost to induce changes in the localization of Rab11 endogenously expressed in the human endothelial EA.hy 926 cell line [42] through stimulation of endogenous hIPs was also examined. In the absence of agonist, 
Effect of Rab4 on Cicaprost-Induced Trafficking of the hIP.
Another member of the Rab family shown to be important in GPCR recycling is Rab4, which exhibits overlapping distribution with both Rab5 and Rab11 in early and recycling endosomes [44] . In view of the findings of a direct role for Rab5a in agonist-induced internalization of the hIP [35] , coupled to the data herein involving Rab11a, it was also sought to establish whether Rab4 may also play a role in trafficking/recycling of the hIP in response to cicaprost. Initially, the effect of over-expression of Rab4a, Figure 1A ). In addition, over-expression of either Rab4a, the dominant negative Rab4a S22N or the constitutively active Rab4a Q67L variant had no measurable effect on the overall recycling of the hIP relative to that observed in either mock-transfected cells (p = 0.8784; p = 0.7444 and p = 0.5842, respectively; ANOVA) or non-transfected cells (data not shown).
However, as the ELISA-based assay can only measure nett changes in cell surface expression, we also investigated whether the hIP may undergo agonist-induced localization to Rab4 endosomes through confocal imaging. In resting cells, the pre-immunolabelled hIP was detected at the cell surface while GFP-Rab4a displayed diffuse cytosolic staining with no co-localization between the pre-labelled hIP and Rab4a evident ( Figure 6A ; 0 hr). Consistent with its ability to undergo cicaprost-induced internalization, the hIP moved from the cell surface into discrete intracellular endosomal vesicles in a time-dependent manner, such that at 2 hr post-agonist stimulation most of it was found intracellular while at 4 hr there was evidence of hIP recycling to plasma membrane ( Figure 6A ; anti-HA). Coincident with this, in response to cicaprost-stimulation there was a time-dependent relocalization of GFP-Rab4a into more discrete, enlarged endosomal vesicles, while at 4 hr post-stimulation it regained the diffuse cytosolicstaining pattern associated with resting cells ( Figure 6A ; GFP-Rab4a). In the overlay images, there was significant time-dependent co-localization of the hIP with many of the enlarged Rab4-associated endosomal vesicles post-cicaprost stimulation (e.g at 0.5 -2hr), while at 4 hr their co-localization in endosomal structures was substantially reduced ( Figure 6A ; Overlay). While over-expression of GFP-Rab4a S22N did not impair the ability of the hIP to undergo similar time-dependent internalization and recycling in response to cicaprost-stimulation, GFP-Rab4a S22N showed diffuse cytoplasmic staining and did not relocalize to discrete enlarged endosomal structures and there was no significant co-localization between the hIP and GFP-Rab4a S22N either in the absence or presence of agonist (Supplemental Figure  1B ). Conversely, expression of the constitutively active, GTPase deficient GFP-Rab4a Q67L did not affect agonist-induced internalization and recycling of the hIP, it promoted the formation and recruitment of the hIP into enlarged Rab4a Q67L positive endocytic vesicles, with substantial co-localization evident at 0.5 -2 hr post agonist stimulation, while at 4 hr much of the hIP was located at the cell surface (Supplemental Figure 1C ).
Collectively these latter data suggest that while over-expression of Rab4a did not appear to significantly enhance the overall levels/nett recycling of the hIP to the cell surface in response to cicaprost stimulation as measured by the ELISA assay, the imaging data show that there is indeed a transient relocalization of the hIP to Rab4-containing endosomes. Consistent with this, stimulation of endogenous hIPs expressed in the endothelial EA.hy 926 cell line with cicaprost also led to a substantial timedependent re-localization of endogenous Rab4 ( Figure 5B) , with evidence of the Rab4-positive endoctyic vesicles coalescing into more punctate, some of which were significantly larger vesicles from 1 hr onward and which showed positive co-staining for the transferrin receptor ( Figure 5D ; 3 hr). These data in EA.hy 926 cells confirm that agonist-activation of the hIP leads to active participation of Rab4 and, similar to that of Rab11, corroborate our findings in HEK293 cells indicating that they are not an artifact of a cell line or expression system.
Thereafter, through co-immunoprecipitation studies, it was also sought to investigate whether Rab4a might physically associate with the hIP expressed in HEK.hIP cells. In the absence of agonist, Rab4a was not detected in the anti-HA immunoprecipitates unlike that of Rab11a, which served as a control ( Figure 6B ). Moreover, consistent with our previous findings (Figure 2A ), while stimulation of HEK.hIP cells with cicaprost (1 µM; 2 hr) yielded a significant increase in the level of Rab11a present in the immunoprecipitates ( Figure 6B & 8) , Rab4a was not found in the anti-HA immunoprecipitates following short term (0 -120 min; Figure 6D , upper panel) or long term (4 hr; data not shown) exposure to cicaprost. Failure to detect Rab4a in the anti-HA immunoprecipitates was not due to differences in hIP (data not shown) or in Rab4a ( Figure 6B , upper and lower panels) expression levels or in the efficiency of the immunoprecipitations per se ( Figure 6B ; middle panel). Collectively these data confirm that the hIP co-localizes with Rab4a, albeit transiently, in response to cicaprost stimulation. However, unlike that of Rab11a, these cicaprost-induced responses do not involve a direct association of Rab4a with the hIP in mammalian HEK 293 cells. Furthermore, these latter data confirm the specificity of the direct interaction of Rab11a with the hIP.
Identification of the Domain(s) within the hIP Mediating Interaction with Rab11a.
Hence, thereafter, it was sought to identify the structural domain(s) within the hIP that mediates its interaction with Rab11a initially through the use of the Y2H approach for the identification of interactions between Rab11a, as prey protein, and various intracellular sub-domains of the hIP acting as specific baits ( Figure 7) . In all, some 12 bait proteins, corresponding to either the intracellular loops 1 -3 (IC 1 -IC 3 ) of the hIP or various sub-fragments of its C-tail domain were tested (Figure 7 ).
In agreement with the initial screen, both the hIP 299-386,WT and hIP 299-386,SSLC showed evidence of interaction with Rab11a as indicated by growth of diploids on QDO selection plates and LacZ reporter gene expression ( Figure 7B & Supplemental Figure 2 ). Conversely, there was no specific interaction between the hIP 320-386WT and Rab11a suggesting that residues Val 299 -Gln 320 , at least, are specifically required for such interaction. Moreover, consistent with this, the equivalent non-isoprenylated hIP 320-386SSLC did not interact with Rab11a and further suggested that the interaction with Rab11a is not largely affected by the isoprenylation status of the hIP. To further investigate the requirement of residues Val 299 -Gln 320 , two additional sub-deletions of the hIP 299-386WT / hIP 299-386SSLC bait proteins that either retain (hIP 307-386WT / hIP 307-386SSLC ) or loose Cys 308 -Cys 311 (hIP 312-386WT / hIP 312-386SSLC ) were tested. Neither the hIP 307-386 nor the hIP 312-386 based on either the wild-type -CAAX motif ( Figure 7B ) or on the -SSLC variant (data not shown) showed any interaction with Rab11a. On the other hand, the hIP 299-320 bait protein showed strong interaction with Rab11a, as assessed by growth on QDO plates and LacZ reporter gene expression ( Figure 7B & Supplemental Figure 2 ). These data suggest that residues Val 299 -Gln 320 mediate the interaction between the C-tail domain of the hIP and Rab11a.
Thereafter, using a similar approach, we also investigated whether any of the other intracellular domains, namely IC 1 -IC 3 , may also interact with Rab11 and in so doing sought to ascertain whether they also contribute to the over-all interaction between the hIP and Rab11. Neither the IC 1 , IC 2 nor IC 3 domains showed any interaction with Rab11a through growth on QDO plates or β-Gal assays ( Figure   7B ). Throughout these studies, the specificity of the interactions between Rab11a and the various bait proteins based on the hIP was confirmed whereby Rab11a failed to show any interaction with either the GAL4 DNA binding domain itself, as encoded by the empty pGBKT7 bait vector, or with p53 protein, acting as an unrelated control protein. Taken together, these data suggest that the Rab11a specifically and directly interacts with the C-tail domain but not with the intracellular loops (IC 1 , IC 2 or IC 3 ) of the hIP and, more specifically, that residues Val 299 -Gln 320 are required and sufficient to mediate that interaction, in the S.cerevisiae-based expression system at least.
Hence, bearing this in mind, it was sought to investigate the role of the C-tail domain of the hIP in mediating its interaction with Rab11a in mammalian HEK 293 cells and as a function of cicaprost stimulation. To this end, we used two previously characterized cell lines, namely HEK.hIP ∆312 and HEK.hIP ∆307 cells that stably over-express the truncated variants hIP ∆312 (devoid of the terminal residues 312-386, including the '-CAAX' motif) and hIP ∆307 (devoid of the terminal residues 307-386, including the palmitoylated residues at Cys 308 and Cys 311 and the '-CAAX' motif), respectively [18] . Both the HEK.hIP ∆312 and HEK.hIP ∆307 cell lines express near equivalent levels of the hIP ∆312 and hIP ∆307 , respectively [17, 18] . From co-immunoprecipitation studies, consistent with our previous data (Figure 2) , it was confirmed that in the absence of agonist-stimulation, GFP-Rab11a was readily detected in the anti-HA -immunoprecipitates from the control HEK.hIP cells and, in response to cicaprost-treatment, there was a time-dependent increase in association of Rab11a with the wild type hIP with maximal response at 2 hr ( Figure 8A, upper panel) . Conversely, Rab11a was not found in the anti-HA immunoprecipitates from HEK.hIP ∆312 or HEK.hIP ∆307 in the absence of agonist and only showed a modest association with the hIP ∆312 , but not with the hIP ∆307 , following cicaprost stimulation ( Figure 8A, upper panel) . Moreover, the specificity of the interaction between the hIP and Rab11a was further confirmed by the fact that Moreover, through Elisa-based assays it was established that in contrast to that which occurred for the wild type hIP, over-expression of Rab11a did not increase the recycling of hIP ∆312 or hIP ∆307 over that level observed in the control pcDNA3-transfected cells ( Figure 8B & Figure 4B ).
Finally, we investigated whether the hIP ∆312 and hIP ∆307 expressed at the cell surface co-localize with Rab11 endosomes in response to cicaprost, as observed with the wild type hIP ( Figure 3A ). In the absence of agonist, both the pre-immunolabelled hIP ∆312 and hIP ∆307 were predominantly detected at the cell surface while GFP-Rab11a exhibited diffuse intracellular staining (Figure 9 , 0 hr). Following 2 hr cicaprost-treatment, there was a significant re-localization of Rab11a to more dispersed vesicular endosomes and significant internalization of the wild-type hIP away from the cell surface into punctate intracellular vesicles with significant co-localization of the hIP to the Rab11-containing endosomes evident ( Figure 3A & Figure 9 , hIP WT , 2 hr). In contrast to this, the recruitment of both hIP ∆312 and hIP ∆307 into intracellular vesicular structures following 2 hr cicaprost-stimulation was substantially impaired (Figure 9 , hIP ∆312 or hIP ∆307 , 2 hr). Moreover, unlike that which occurred in the HEK.hIP cells, Rab11a did not undergo a significant relocalization to vesicular endosomal structures in either HEK.hIP ∆312 or HEK.hIP ∆307 cells in response to cicaprost-treatment and the extent of co-localization of the hIP ∆312 or hIP ∆307 with Rab11a was substantially reduced.
Taken together, these data confirm that the C-tail domain is critical in mediating direct association of the hIP with Rab11a in mammalian cells and that, in response to cicaprost stimulation, the hIP:Rab11 complex co-localize in Rab11-containing late recycling endosomes, an effect not observed in the case of either the hIP ∆312 or hIP ∆307 . Moreover, from studies in yeast, we have identified a 22 amino acid segment, corresponding to Val 299 -Gln 320 , located proximal to transmembrane 7 as a critical subdomain in mediating direct association between the hIP and Rab11a.
DISCUSSION
Prostacyclin is a critical endogenous autocoid that not only plays a central role in regulating haemostasis and vascular tone, but is also a potent pro-inflammatory and pro-nociceptive mediator and contributes to a variety of (patho)physiologic processes [1, 45] . Hence, understanding the mechanisms whereby the cellular responses to prostacyclin are dynamically regulated is critical to the understanding of its role in such processes at the detailed molecular level. While much is known about the modes of intracellular signalling by the prostacyclin receptor (IP) and the events leading to its desensitization and internalization, significantly less is understood about the intracellular sorting mechanisms dictating its recyclization or other trafficking following agonist stimulation [14, [32] [33] [34] [35] 46] . Herein, we have uncovered a novel direct association between the hIP and the GTPase Rab11a that regulates its recycling to the plasma membrane following agonist stimulation.
The hIP is somewhat unique among members of the GPCR superfamily in that it is undergoes both isoprenylation (farnesylation at Cys 383 ) and palmitoylation (at Cys 308 and Cys 311 ) within its C-tail domain, and collectively, these modifications are critical in mediating its G-protein: effector coupling /signalling and in regulating its internalization post-agonist stimulation [16] [17] [18] . Moreover, consistent with the latter findings, it was recently established that the hIP undergoes rapid agonist-induced internalization through a mechanism involving its direct interaction with Rab5a [35] . While deletion of the C-tail domain of the hIP did not fully impair its internalization or abolish its interaction with Rab5a per se, agonist-induced trafficking of its variants hIP ∆312 and hIP ∆307 was substantially altered suggesting that the C-tail domain may contain key structural determinant(s) regulating its intracellular trafficking post-agonist stimulation [35] . Herein, we employed the Y2H system to screen a human kidney cDNA library for proteins that interact with the C-tail (residues 299-386) domain of the hIP. Amongst those protein interactants, we identified several independent clones encoding Rab11a that specifically interacted with both the non-isoprenylated (hIP 299-386SSLC ) and wild type, isoprenylated (hIP 299-386WT ) forms of the hIP. It is noteworthy that from our Y2H screen we also identified cGMP phosphodiesterase (PDE) 6δ as an interactant of the C-tail domain of the hIP but which, consistent with a previous study [47] , specifically interacted with the wild type isoprenylated (-CSLC) but not with the non-isoprenylated (-SSLC) form (data not shown).
The direct interaction between Rab11a and the hIP was confirmed herein in mammalian HEK 293 cells and was found to be constitutive but was significantly enhanced in response to cicaprost-stimulation, with maximal interaction observed at 2 hr post-agonist stimulation. Moreover, the dominant negative Rab11 S25N and GTPase defective Rab11 Q70L showed similar constitutive and cicaprost-enhanced association with the hIP suggesting that GDP/GTP-exchange on Rab11 is not a rate-limiting determinant for the specific interaction per se. Through confocal-imaging, it was found that the cell-surface hIP re-localized to Rab11a-endosomes with maximal co-localization observed at 2 hr post-cicaprost stimulation and thereafter, a proportion of the internalized hIP (~ 50%) recycled to the plasma membrane at 4 hr.
Consistent with the latter, in the presence of Rab11a Q70L , the hIP showed increased cicaprost-induced colocalization while it exhibited substantially less co-localization with-and underwent impaired recycling in the presence of Rab11a S25N . These data were corroborated using an ELISA-based internalization assay to track nett changes in cell surface expression of the hIP. In addition, stimulation of endogenous hIPs expressed in the human endothelial EA.hy 926 cells [42] also led to time-dependent redistribution of Rab11 from a dispersed cytosolic localization to more discrete vesicular structures suggesting that observed effect of Rab11 on hIP internalization are not a simple artifact of their over-expression, and can occur in more physiologically relevant cell types and expression levels. It should be noted that in the absence of proprietary antibodies directed to the hIP itself, we sourced and tested several commercial samples, but found that they were not of sufficient quality or specificity to allow for coimmunolocalization of the endogenous hIPs in the EA.hy 926 cells along with Rab11 (data not shown).
The time-dependent redistribution of Rab11 in the EA.hy 926 cells paralleled the time-dependent increased interaction of the hIP with Rab11a in HEK293 cells, as monitored by the coimmunoprecipitations and confocal imaging data. Collectively, these data indicate that the hIP directly and constitutively interacts with Rab11a but that in response to cicaprost-stimulation, such interactions are significantly augmented. Hence, as has been suggested for other GPCRs [44] , it appears that the hIP does not simply act as passive cargo in the endocytic and recycling process but may directly influence the Rab11a GTPase and, in so doing, directly control its own targeting and transport between intracellular compartments.
Rab proteins are increasingly implicated in the internalization and trafficking of members of the GPCR superfamily, offering alternative or complementary mechanisms to the more classic GRK/βarrestin-dependent pathways to fine-tune the signalling responses following agonist activation [20, 44] .
Rab4, Rab5 and Rab11 show over-lapping distribution in early and recycling endosomes [44] while Rab11 is also present on the pericentriolar recycling endosome and is associated with the 'long or slow recycling pathway' [48] , distinct from the more direct, shorter pathway involving Rab4-positive vesicles [49, 50] . For example, Rab4a mediates the rapid recycling of the transferrin receptor from Rab5a-positive sorting endosomes while Rab11a is required for its slow recycling from perinuclear endosomes [28] .
Rab11 also participates in the slow recycling of other GPCRs, including the angiotensin II type 1A receptor, the CXCR2 receptor, the neurokinin 1 receptor, the M 4 muscarinic acetylcholine receptor and β 2 -adrenergic receptors [51] [52] [53] [54] [55] . In the context of prostanoid signalling, it is indeed notable that Rab11
regulates the intracellular trafficking of the β-isoform of the human thromboxane (TX) A 2 receptor (TPβ) [56] . The direct association of the hIP with Rab11a is consistent with its slow-recycling to the plasma membrane. However, data herein did not exclude that possibility that the hIP may also undergo more rapid recycling such as through Rab4-containing endosomes. In view of the findings for a direct role of Rab5 in agonist-induced internalization of the hIP [35] , coupled to the data herein involving Rab11a, we also investigated whether Rab4 may also play a role in recycling of the hIP in response to cicaprost.
Initially, using the ELISA-based approach, we found no evidence that over-expression of Rab4a, or indeed its constitutively active Rab4a Q67L or dominant negative Rab4a S22N , conferred a measurable change in the recycling of the hIP in response to cicaprost stimulation. In contrast to this, through confocal imaging, there was indeed substantial evidence of co-localization of the hIP to Rab4a-positive endosomes as early as 30 min following cicaprost stimulation. However, that co-localization was transient such that at 4 hr post-agonist stimulation co-localization in the endosomal structures almost disappeared. Moreover, stimulation of endogenous hIPs expressed in the endothelial EA.hy 926 cells with cicaprost led to time-dependent redistribution of endogenous Rab4 to discrete and enlarged intracellular vesicles, confirming that its involvement can occur at more physiologic levels and that it is not an artifact of the mammalian cell line or expression system. Thereafter, through coimmunoprecipitations from mammalian HEK293 cells, unlike that which occurred herein for Rab11a or previously reported for Rab5a ( [35] ), Rab4a was not found to physically interact with the hIP either constitutively or in response to cicaprost stimulation, even following short-or long-term exposure.
Hence, these data confirm that the hIP co-localizes and leads to activation of Rab4a, albeit transiently, in response to cicaprost stimulation. However, unlike that of Rab11, these cicaprost-induced responses do not involve a direct association of Rab4a with the hIP. It can be reasoned that failure to see any role for Rab4a in the recycling of the hIP as measured by ELISA assessment of cell-surface receptors was most likely due to the fact that Rab4a is involved at an early point in the recycling process, as corroborated by the confocal imaging data herein, at a time where there is unlikely to be a nett balance between internalization and recycling.
As stated, there are numerous examples in the literature whereby Rab4a and Rab11a play exclusive roles in directing the recycling of various GPCRs, through either the fast and slow recycling mechanisms, respectively [51-53, 55, 56] . Even GPCRs that respond to the same ligand, such as the prostanoid D2 receptor and the CRTH2 (chemoattractant homologous receptor expressed on TH2 cells) undergo distinct routes of recycling via Rab4 and Rab11, respectively, following stimulation with prostaglandin D 2 [57] . Conversely, substance P (SP) induces the internalization of the neurokinin 1 receptor (NK1R) in epithelial cells through a Rab5a-dependent mechanism but it appears that the route of recycling is dependent on the agonist concentration [54] . Specifically, at low concentrations of SP (1 nM), recycling of the NK1R is from early endosomes through a Rab4a-dependent route while at higher concentrations (10 nM), recycling occurs through a Rab11a-dependent mechanism from perinuclear endosomes [54] . While we have not, as yet, investigated the possibility of an exclusive agonist concentration-dependent involvement of Rab4a versus Rab11a in the recycling of the hIP, our data herein present a compelling case for a specific and unique involvement of Rab11a in its recycling that involves a direct interaction with the hIP.
Through the Y2H approach, it was established that both the non-isoprenylated hIP 299-386,SSLC and the wild type isoprenylated hIP 299-386,WT showed strong and comparable interaction with Rab11a, suggesting that the specific interaction is not influenced by the isoprenylation status of the hIP.
Conversely, there was no specific interaction between any of the other intracellular domains suggesting that neither IC 1 , IC 2 or IC 3 contribute to the overall interaction between the hIP and Rab11a but that, more specifically, the interaction is exclusively dependent on sequences within the C-tail domain, as assessed by the Y2H approach at least. Furthermore, there was no specific interaction between the hIP 320-386,WT , or indeed its non-isoprenylated hIP 320-386,SSLC equivalent, and Rab11a suggesting that residues Val 299 -Gln 320 , at least, are specifically required for such interaction. As stated, the hIP is both farnesylated, at Cys 383 , and dually palmitoylated, at Cys 308,311 , and collectively these modifications play a key role in regulating its G protein coupling and signalling and its agonist-induced internalization [16] [17] [18] 58] .
Hence, we also examined two additional sub-deletions of the hIP 299-386WT , that either retained, namely hIP 307-386,WT , or lost, namely hIP 312-386,WT , the palmitoylated Cys 308 and Cys 311 residues and found that neither the hIP 307-386 nor the hIP 312-386 showed any interaction with Rab11a. On the other hand, the bait protein hIP 299-320 showed strong interaction with Rab11a. These data clearly demonstrated that residues Val 299 -Gln 320 are required and sufficient to mediate the interaction between the C-tail domain of the hIP and Rab11a and that even minimal deletion of residues 299 -307, as in the hIP 307-386,WT , or residues 299-312, as in hIP 312-386,WT , prevented the interaction. The specific requirement for the C-tail domain of the hIP in mediating its interaction with Rab11a was further confirmed in mammalian HEK 293 cells whereby Rab11a did not substantially co-precipitate with the truncated variants hIP ∆312 and hIP ∆307 either in the absence of or following cicaprost stimulation. Moreover, unlike that which occurred for the hIP, Rab11a did not re-localize to vesicular endosomal structures in either HEK.hIP ∆312 or HEK.hIP ∆307 cells in response to cicaprost-treatment and the extent of co-localization of the hIP ∆312 or hIP ∆307 with Rab11a was significantly reduced. Taken together, these data confirm that the C-tail domain is critical in mediating direct association of the hIP with Rab11a in mammalian cells and, from studies in yeast, we have identified a 22 amino acid segment, corresponding to Val 299 -Gln 320 , located proximal to transmembrane 7 as a critical subdomain in mediating direct association between the hIP and Rab11. Failure to detect interaction between Rab11a and other subdomains of the hIP as assessed through the Y2H system did not exclude the possibility that other regions or subdomains of the receptor may also contribute to or influence the interaction, such as in mammalian systems. In fact, the co-immunoprecitation studies did reveal a weak interaction between Rab11a and hIP ∆312 that increased in response to agonist-stimulation suggesting that other regions of the hIP other than Val 299 -Gln 320 may participate in the interaction.
As stated, the hIP is dually palmitoylated at Cys 308 and Cys 311 and together with the farnesyl-Cys 383 -methyl ester, at Cys 383 , it has been proposed to confer a double loop structure within its C-tail domain to orientate and provide the critical structural domains for interaction with coupling G proteins and, possibly, with components of the protein trafficking machinery to modulate both G protein/effector signaling and receptor internalization post-agonist activation [16] [17] [18] . We have not, as yet, investigated the specific requirement of Cys 308 or Cys 311 for the interaction with Rab11a or indeed the involvement of palmitoylation, such as proposed in the latter model. However, owing to our findings demonstrating the specific involvement Val 299 -Gln 320 coupled to requirement of residues N-terminal of Cys 308 /Cys 311 for interaction with Rab11a, it is indeed tempting to speculate that the proposed double loop structure may indeed provide the platform for interaction with Rab11a. Moreover, agonist-regulated palmitoylation/depalmitoylation may provide the dynamic platform to modulate such interactions through the provision of increased hydrophobic protein:membrane and/or protein:protein interactions [18, 59] . Through on-going studies, we propose to investigate these possibilities.
Of course the hIP is not the only GPCR shown to have a direct physical interaction with Rab11a.
Recently Takahashi et al., demonstrated that Rab11a can co-immunoprecipitate with the CXCR2 in neutrophils in response to the anti-inflammatory agent curcumin [60] . Moreover and more specifically in the context of prostanoid receptor signalling, Hamelin et al., [56] provided the first demonstration of a direct interaction between Rab11 and a GPCR, namely the TPβ isoform of the human TXA 2 receptor.
Moreover, they established that amino acids 335-344 within the C-tail, proximal to TM7, of TPβ were specifically required for that interaction with a minor role for the IC 1 also identified [56] . Whilst they too did not discuss the possible involvement of palmitoylation in regulating TPβ interaction with Rab11a, it is also notable that, coincident with that of the hIP, the critical residues within the C-tail domain contain a Cys (namely Cys 343 ) that has been confirmed to undergo palmitoylation [61] and the interacting residues are also located proximal to TM7 within both TPβ and the hIP.
The structural requirement for a hydrophobic binding domain is, in fact, a common feature of other groups of proteins capable of specifically interacting with Rab11 in addition to GPCRs, as exemplified by TPβ [56] and the hIP herein. For example, members of the recently described 'family of Rab11-interacting proteins (FIPs)' contain a highly conserved 20 amino acid motif at their C termini, known as the Rab11/25 binding domain (RBD). Moreover, RBD is found predominantly in a coil-coiled or helical conformation allowing for highly conserved hydrophobic residues therein to form a hydrophobic Rab11 binding patch and substitution of these hydrophobic residues inhibits Rab11 binding to FIPs [62] . The Rab11a binding/interacting domain identified herein within the hIP, corresponding to the 22 amino acid Val 299 -Gln 320 region, is of a similar size to the RBD of the FIPS and, like that of TPβ, is both enriched in hydrophobic residues and is also capable of forming a helical conformation [63] .
Through on-going investigations, we propose to more precisely define the Rab11a binding domain (RBD)
within the hIP and, additionally, to identify the region(s) within Rab11a involved in that interaction.
In summary, we have identified a novel interaction between the hIP and Rab11a that functionally plays a central role in regulating its recycling following agonist-activation. These studies greatly add to the knowledge and understanding of the molecular events regulating the intracellular trafficking of the hIP and of the structural domains required. Moreover, bearing in mind the similar biochemical properties of the Rab11 binding domain identified herein within the hIP to that previously identified within TPβ [56] , both in terms of the presence of palmitoylable -Cys residues and capacity to adopt a helical coilconformation coupled to their location within the C-tail domains of their respective receptors proximal to transmembrane (TM) 7, these studies may have uncovered a more general mechanism for regulating Rab11-mediated intracellular trafficking of other members of the GPCR superfamily. ), S.c AH109 (pGBKT7:hIP 299-386SSLC ) or, as controls, with S.c AH109 (pGBKT7:p53) and S.c AH109 (pGBKT7). Resulting diploid strains were either grown on double dropout (DDO) media (Leu -, Trp -; selection for diploid formation) or on quadruple dropout (QDO) media (Leu -, Trp -, Ade -, His -; selection for positive GAL4-dependent transcriptional regulation owing to interaction between bait and prey proteins). 
